Track the Gubra A/S stock price and the full insider trade history of the company, a listed equity based in Denmark. Shares are listed on the DK market, under the oversight of Finanstilsynet DK. Operating in the Healthcare & Pharma sector, Gubra A/S has recorded 34 public disclosures. Market capitalisation: €5.8bn. The latest transaction was reported on 17 June 2026 (Other). Every trade is openly available.
34
Insider Decl.
n/a
Thresholds
€4m
13 ops.
Buy Volume
€25m
4 ops.
Sell Volume
35Σ signal
Buys €4m€25m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 352 of 29,062 companies
86.5
score / 100
Value
97
Quality
76
FCF yld27%
Earn yld26%
EV/EBITDA3.0x
ROE-16%
Gross mgn97%
Net mgn64%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
20,189 shares0ShareOutside a trading venueISINISIN DK0062266474DK:1231786
25 of 34 declarations
Acerca de Gubra A/S
Gubra A/S es una empresa danesa centrada en la investigación y el desarrollo de tratamientos para enfermedades metabólicas. Destaca la innovación en los sectores de la salud y la farmacia.